RxDoctor Payments Data

Frank Kimsey, MD

Radiation Oncology · Chattanooga, TNNPI 1619062924

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,600 of the $5,424 with a category attached, or 66.4%. Novocure Inc. accounts for 88.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,646 and has fallen 95.5% since, to $207 in 2025.

$5,424in general payments, 2019–2025

Across 35 payments — averaging $154.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$5K
  • Accuray Incorporated$139
  • Progenics Pharmaceuticals, Inc.$114
  • Bayer$107
  • GT Medical Technologies, Inc$62
  • Regeneron Healthcare Solutions, Inc.$59
  • plus $135 from 5 others

What the payments were for

  • Speaking & faculty fees$3,60066%
  • Travel & lodging$62111%
  • Food & beverage$1,20422%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,424 in reported general payments places this provider in the 85th percentile of 115 radiation oncology providers in Tennessee.

See all radiation oncology providers in Tennessee

Medicare billing

Part B allowed, 2024
$205,811
Medicare patients
209
Services billed
2,312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →